These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 21942816)

  • 1. Sensitive quantification of somatic mutations using molecular inversion probes.
    Hirani R; Connolly AR; Putral L; Dobrovic A; Trau M
    Anal Chem; 2011 Nov; 83(21):8215-21. PubMed ID: 21942816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitive multiplex detection of KRAS codons 12 and 13 mutations in paraffin-embedded tissue specimens.
    Laosinchai-Wolf W; Ye F; Tran V; Yang Z; White R; Bloom K; Choppa P; Labourier E
    J Clin Pathol; 2011 Jan; 64(1):30-6. PubMed ID: 21030527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High sensitive mutation analysis on KRAS gene using LNA/DNA chimeras as PCR amplification blockers of wild-type alleles.
    Huang Q; Wang GY; Huang JF; Zhang B; Fu WL
    Mol Cell Probes; 2010 Dec; 24(6):376-80. PubMed ID: 20732413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of low-level KRAS mutations using PNA-mediated asymmetric PCR clamping and melting curve analysis with unlabeled probes.
    Oh JE; Lim HS; An CH; Jeong EG; Han JY; Lee SH; Yoo NJ
    J Mol Diagn; 2010 Jul; 12(4):418-24. PubMed ID: 20413678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid screening assay for KRAS mutations by the modified smart amplification process.
    Tatsumi K; Mitani Y; Watanabe J; Takakura H; Hoshi K; Kawai Y; Kikuchi T; Kogo Y; Oguchi-Katayama A; Tomaru Y; Kanamori H; Baba M; Ishidao T; Usui K; Itoh M; Cizdziel PE; Lezhava A; Ueda M; Ichikawa Y; Endo I; Togo S; Shimada H; Hayashizaki Y
    J Mol Diagn; 2008 Nov; 10(6):520-6. PubMed ID: 18832461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
    Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
    J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of circulating tumor DNA to confirm somatic KRAS mutations.
    Holdhoff M; Schmidt K; Donehower R; Diaz LA
    J Natl Cancer Inst; 2009 Sep; 101(18):1284-5. PubMed ID: 19641175
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel liquidchip platform for simultaneous detection of 70 alleles of DNA somatic mutations on EGFR, KRAS, BRAF and PIK3CA from formalin-fixed and paraffin-embedded slides containing tumor tissue.
    Li G; Luo X; He J; Zhu Z; Yu G; Qin H; Zeng T; Liu Z; Wu S; Xu J; Ren-Heidenreich L
    Clin Chem Lab Med; 2011 Feb; 49(2):191-5. PubMed ID: 21118047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation pattern of KRAS and BRAF oncogenes in colorectal cancer patients.
    Rako I; Jakic-Razumovic J; Katalinic D; Sertic J; Plestina S
    Neoplasma; 2012; 59(4):376-83. PubMed ID: 22489692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KRAS mutations in patients with colorectal cancer as detected by high-resolution melting analysis and direct sequencing.
    Akiyoshi K; Yamada Y; Honma Y; Iwasa S; Kato K; Hamaguchi T; Shimada Y; Taniguchi H; Furuta K
    Anticancer Res; 2013 May; 33(5):2129-34. PubMed ID: 23645765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA.
    Heideman DA; Lurkin I; Doeleman M; Smit EF; Verheul HM; Meijer GA; Snijders PJ; Thunnissen E; Zwarthoff EC
    J Mol Diagn; 2012; 14(3):247-55. PubMed ID: 22425762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in mutational status during third-line treatment for metastatic colorectal cancer--results of consecutive measurement of cell free DNA, KRAS and BRAF in the plasma.
    Spindler KL; Pallisgaard N; Andersen RF; Jakobsen A
    Int J Cancer; 2014 Nov; 135(9):2215-22. PubMed ID: 24659028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wobble-enhanced ARMS method for detection of KRAS and BRAF mutations.
    Hamfjord J; Stangeland AM; Skrede ML; Tveit KM; Ikdahl T; Kure EH
    Diagn Mol Pathol; 2011 Sep; 20(3):158-65. PubMed ID: 21817902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of KRAS codon 12 and 13 mutations by mutant-enriched PCR assay.
    Chang YS; Er TK; Lu HC; Yeh KT; Chang JG
    Clin Chim Acta; 2014 Sep; 436():169-75. PubMed ID: 24863805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Consensus for KRAS gene mutation detection in colorectal carcinoma].
    Pathology Quality Control Center of China, Consensus Group for KRAS Gene Mutation Detection in Colorectal Carcinoma
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):635-6. PubMed ID: 23157836
    [No Abstract]   [Full Text] [Related]  

  • 16. Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability.
    Umeda Y; Nagasaka T; Mori Y; Sadamori H; Sun DS; Shinoura S; Yoshida R; Satoh D; Nobuoka D; Utsumi M; Yoshida K; Yagi T; Fujiwara T
    J Hepatobiliary Pancreat Sci; 2013 Feb; 20(2):223-33. PubMed ID: 23010994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACB-PCR quantification of somatic oncomutation.
    Myers MB; McKinzie PB; Wang Y; Meng F; Parsons BL
    Methods Mol Biol; 2014; 1105():345-63. PubMed ID: 24623241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LNA-based PCR clamping enrichment assay for the identification of KRAS mutations.
    Efrati E; Elkin H; Peerless Y; Sabo E; Ben-Izhak O; Hershkovitz D
    Cancer Biomark; 2010-2011; 8(2):89-94. PubMed ID: 21896996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KRAS and BRAF mutational status in primary colorectal tumors and related metastatic sites: biological and clinical implications.
    Italiano A; Hostein I; Soubeyran I; Fabas T; Benchimol D; Evrard S; Gugenheim J; Becouarn Y; Brunet R; Fonck M; François E; Saint-Paul MC; Pedeutour F
    Ann Surg Oncol; 2010 May; 17(5):1429-34. PubMed ID: 20049644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of KRAS mutations in colorectal cancer with Fast COLD-PCR.
    Carotenuto P; Roma C; Cozzolino S; Fenizia F; Rachiglio AM; Tatangelo F; Iannaccone A; Baron L; Botti G; Normanno N
    Int J Oncol; 2012 Feb; 40(2):378-84. PubMed ID: 21971641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.